<p>The primary goal of this project involves the comprehensive molecular profiling of patient-derived xenograft (PDX) mouse tumor models. Molecular profiling of each PDX model will include whole exome sequencing (WES), RNAseq, MethylEPIC arrays, CytoSNP array, and DNA fingerprint for quality control. Limited clinical demographic data (e.g. diagnosis, disease site, disease status) will be obtained. This data can be utilized to validate PDX models with matched patient tumors and can be used to guide model selection for downstream preclinical drug testing. </p>

Childhood Cancer Data Initiative (CCDI): Pediatric In Vivo Testing    Program – Sarcomas and other Solid Tumors

Heterografts study with AMPLICON data on dbGaP (175 participants)